The Source
|
Connect to the global Plasma Protein industry: |
| Read the new Special Feature "COVID-19 Convalescent Plasma and a New Therapy — COVID-19 Immune Globulin," an interview with Dr. Dorothy Scott, M.D., Chief, Plasma Derivatives Branch, Division of Plasma Protein Therapeutics, Office of Tissues And Advanced Therapies, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration. |
Read the full issue: Winter 2020
Past Issues
2020-2016
2015-2011
If you need a copy of an article or would like permission to reprint please contact Mat Gulick.